Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Influenza Vaccinations”

155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 155 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04613206
What this trial is testing

High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients

Who this might be right for
Immunization; InfectionTransplantation InfectionInfluenza+1 more
Vanderbilt University Medical Center 396
Post-approval studies (Phase 4)UnknownNCT01967368
What this trial is testing

Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults

Who this might be right for
Influenza, Human
The University of Hong Kong 100
Post-approval studies (Phase 4)Looking for participantsNCT07838298
What this trial is testing

Influenza Vaccine Immunogenicity in Repeatedly Vaccinated Older Adults

Who this might be right for
Influenza VaccinationOlder Adults (65 Years and Older)Immunosenescence+2 more
Korea University Guro Hospital 180
Post-approval studies (Phase 4)Study completedNCT00743275
What this trial is testing

Evaluate the Safety and Immune Responses to Fluzone® Vaccination

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 120
Testing effectiveness (Phase 2)Study completedNCT03682120
What this trial is testing

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 372
Not applicableStudy completedNCT01652066
What this trial is testing

Effect of a Mixture of Probiotics on the Antigen Specific Antibody Response in a Influenza Vaccination Model of Healthy Adults

Who this might be right for
Enhancement of Protective Antibody Response After Probiotic Consumption
Merck Medication Familiale 430
Large-scale testing (Phase 3)Study completedNCT01229371
What this trial is testing

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers

Who this might be right for
Influenza
Crucell Holland BV 440
Large-scale testing (Phase 3)Study completedNCT00848029
What this trial is testing

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules

Who this might be right for
Pre-pandemic Influenza Vaccine
Novartis Vaccines 240
Testing effectiveness (Phase 2)Study completedNCT05650554
What this trial is testing

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 682
Testing effectiveness (Phase 2)Study completedNCT00895544
What this trial is testing

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Who this might be right for
InfluenzaAvian Influenza
Alachua Government Services, Inc. 231
Not applicableStudy completedNCT02284594
What this trial is testing

Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts

Who this might be right for
Influenza
Columbia University 4,026
Large-scale testing (Phase 3)Study completedNCT00616928
What this trial is testing

Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years

Who this might be right for
Influenza
GlaxoSmithKline 4,561
Not applicableStudy completedNCT03478254
What this trial is testing

Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-1).

Who this might be right for
Type 1 Diabetes Mellitus
Jesús Moreno Fernández 300
Not applicableStudy completedNCT02907645
What this trial is testing

Influenza Vaccine Randomized Educational Trial: Adult

Who this might be right for
VaccinationInfluenza
Columbia University 222
Large-scale testing (Phase 3)Study completedNCT01773928
What this trial is testing

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 1,928
Post-approval studies (Phase 4)Study completedNCT02141581
What this trial is testing

Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)

Who this might be right for
Influenza
Stanford University 86
Early research (Phase 1)Study completedNCT05829356
What this trial is testing

Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 159
Large-scale testing (Phase 3)Not Yet RecruitingNCT07133802
What this trial is testing

Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination

Who this might be right for
Prevention of Influenza
Changchun BCHT Biotechnology Co. 6,680
Post-approval studies (Phase 4)Not Yet RecruitingNCT07726862
What this trial is testing

How Healthy Adults Respond to the Nasal Flu Vaccine

Who this might be right for
Mucosal Immune Response to Influenza Vaccination
University of Alabama at Birmingham 20
Post-approval studies (Phase 4)Study completedNCT01649713
What this trial is testing

Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 120
Next Page